The International Master's Programme in Innovative Medicine (IMIM) is a collaboration between Uppsala University (Sweden), the University of Groningen (the Netherlands), Heidelberg University (Germany) and the University of Tartu (Estonia) where admitted students study year 1 at any partner university and year 2 at either Groningen, Uppsala or Tartu. This means that there are four possible study plans where special regulations of admission for IMIM and the involved partner universities must be fulfilled. Starting at Uppsala University A Bachelor's degree, equivalent to a Swedish Kandidatexamen, from an internationally recognised university. The degree must be in biochemistry/chemistry, biology, biomedicine/medicine, biotechnology, cell/molecular biology, genetics, life science, medical sciences or a similar field of study including courses in biochemistry, cell biology, chemistry, genetics, and molecular biology/-genetics of a total of at least 30 credits as well as knowledge and previous experience of related laboratory work. Starting at the University of Groningen A Bachelor's degree in the fields of biology, pharmacy, life science and technology or (bio)medical sciences. Starting at Heidelberg University A Bachelor's degree with a fixed standard period of study of at least four academic years (240 ECTS; equivalent degrees may be accepted) with above-average grades. In exceptional cases, participants of the IMIM programme may be admitted to the programme with a degree worth only 180 ECTS, provided they are able to submit proof that the outstanding 60 ECTS will be earned no later than by the end of the IMIM programme. The degree needs to be in medicine or the life sciences (e.g. biology, biochemistry, pharmaceutical sciences, biomedical sciences, genetics, molecular biology, biotechnology, health sciences or closely related fields). Proven record of academic and extra-curricular excellence as well as research experience. Strong motivation to pursue a career that incorporates translational, biomedical sciences and research. Starting at the University of Tartu A Bachelor's degree or equivalent qualification in the natural and exact sciences or in the field of medicine. Additionally, eligibility for IMIM and all four partner universities requires documented knowledge of English with results from an internationally accepted test. The minimum test scores are: IELTS (Academic) with an overall score of 6.5 and no less than 6.0 on each section, or Cambridge Certificate of Proficiency in English (CPE)/ Cambridge Certificate of Advanced English (CAE) with a minimum score of 180. TOEFL IBT (internet-based test) with an overall score of 92 and no less than 21 on each section.
Translational medicine strives toward bridging the gap from the research bench to the patient's bedside by the development of novel diagnostics and treatments. This is the core of the International Master's Programme in Innovative Medicine - a two-year programme aiming to provide knowledge, skills and competencies for your future careers in interdisciplinary and internationally competitive academic research or the private sector. The International Master's Programme in Innovative Medicine (IMIM) is a two-year international joint Master's programme focusing on translational medical research, modern molecular techniques, innovation and entrepreneurship. The programme is a European collaboration between the University of Groningen in The Netherlands, Heidelberg University in Germany, the University of Tartu in Estonia and Uppsala University in Sweden. Several international Life Science companies are associated with the programme as well as other universities in Brazil, Chile, Colombia, Mexico and Japan. The IMIM programme trains you for research in both academia and industry, for example through a multidisciplinary group project - Bench to Bedside and Beyond (BBB), focused on translational medicine and the innovation process with business and entrepreneurship. The programme courses